Nature profiles College of Medicine neuroscience doctoral student Christin Godale
Christin Godale, a doctoral student in the Neuroscience Graduate Program, was recently featured in an article in Nature highlighting her advocacy work for neuroscience funding.
Godale was diagnosed at age 2 with epilepsy, which led to her interest in neuroscience. She works with the Society for Neuroscience and has met with federal policymakers and elected officials to increase funding for research.
“Like many people with epilepsy, I rely on anti-seizure medications, which allow me to pursue my dreams and ambitions. Advocating for basic science is very personal for the epilepsy community and myself. Researchers should consider the voices of patient advocates when performing basic research, writing a grant application or giving a scientific presentation,” she says in the article.
Godale works in the laboratory of Steve Danzer, PhD, associate professor in the Department of Anesthesiology, at Cincinnati Children’s.
Last year Godale was selected as an award recipient of the National Institutes of Health (NIH) Outstanding Scholars in Neuroscience Award Program, which recognizes early-career scientists who are conducting exceptional research and who have great academic potential in their scientific training. She also has received an NIH Predoctoral Fellowship from the National Institute of Neurological Disorders and a Predoctoral Fellowship from the American Epilepsy Society.
UC College of Medicine graduate student Christin Godale. (Photo courtesy of Cincinnati Children's)
Featured image at top: Christin Godale/Colleen Kelley/UC Creative + Brand.
Tags
Related Stories
Chris Higgins named UC Foundation Vice President for Development, Academic Health Enterprise
January 6, 2026
The University of Cincinnati Foundation is pleased to welcome Chris Higgins as the new Vice President for Development, Academic Health Enterprise.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.